Author

Michele Citrano

A PROPENSITY SCORE-MATCHED COMPARISON OF INFLIXIMAB AND ADALIMUMAB IN NAïVE AND NON-NAïVE PATIENTS WITH CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Ambrogio Orlando, Fabio Salvatore Macaluso, Walter Fries, Antonio Carlo Privitera, Maria Cappello, Sebastiano Siringo, Gaetano Inserra, Antonio Magnano, Roberto Di Mitri, Filippo Mocciaro, Nunzio Belluardo, Giuseppe Scarpulla, Giovanni Magri, Antonino Trovatello, Antonio Carroccio, Salvatore Genova, Carmelo Bertolami, Robe

A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Maria Cappello, Barbara Scrivo, Antonio Magnano, Dario Pluchino, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Giovanni Magri, Concetta Ferracane, Michele Citrano, Francesco Graziano, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia

THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): PRELIMINARY DATA ON EFFICACY OF BIOLOGICAL THERAPY

Ambrogio Orlando, Fabio Salvatore Macaluso, Walter Fries, ANTONINO CARLO Privitera, Maria Cappello, Sebastiano Siringo, Gaetano Inserra, Antonio Magnano, Roberto Di Mitri, N Belluardo, Giuseppe Scarpulla, Giovanni Magri, Antonino Trovatello, Antonio Carroccio, Salvatore Genova, Carmelo Bertolami, Roberto Vassallo, Claudio

Item 1 - 3 / 3
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK